183 related articles for article (PubMed ID: 11891039)
1. Low morbidity of bronchoplastic procedures after chemotherapy for lung cancer.
Veronesi G; Solli PG; Leo F; D'Aiuto M; Pelosi G; Leon ME; De Braud F; Spaggiari L; Pastorino U
Lung Cancer; 2002 Apr; 36(1):91-7. PubMed ID: 11891039
[TBL] [Abstract][Full Text] [Related]
2. [Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].
Zhou Q; Shi Y; Chen J; Liu B; Wang Y; Zhu D; Zhang HT; Xu P; Gong Y; Chen G; Wei S; Qiu X; Niu Z; Chen X; Lei Z; Duan L; Wu Z
Zhongguo Fei Ai Za Zhi; 2011 Feb; 14(2):86-106. PubMed ID: 21342639
[TBL] [Abstract][Full Text] [Related]
3. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
4. Morbidity, mortality, and survival after bronchoplastic procedures for lung cancer.
Rea F; Loy M; Bortolotti L; Feltracco P; Fiore D; Sartori F
Eur J Cardiothorac Surg; 1997 Feb; 11(2):201-5. PubMed ID: 9080142
[TBL] [Abstract][Full Text] [Related]
5. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
[TBL] [Abstract][Full Text] [Related]
6. Sleeve lobectomy compared with pneumonectomy after induction therapy for non-small-cell lung cancer.
Maurizi G; D'Andrilli A; Anile M; Ciccone AM; Ibrahim M; Venuta F; Rendina EA
J Thorac Oncol; 2013 May; 8(5):637-43. PubMed ID: 23584296
[TBL] [Abstract][Full Text] [Related]
7. Sleeve lobectomy for carcinoma of the lung.
Weisel RD; Cooper JD; Delarue NC; Theman TE; Todd TR; Pearson FG
J Thorac Cardiovasc Surg; 1979 Dec; 78(6):839-49. PubMed ID: 228125
[TBL] [Abstract][Full Text] [Related]
8. Postoperative complications of lung resection after induction chemotherapy using Paclitaxel (and radiotherapy) for advanced non-small lung cancer.
Torre W; Sierra A
J Cardiovasc Surg (Torino); 2002 Aug; 43(4):539-44. PubMed ID: 12124570
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes of sleeve resections performed for non-small cell lung cancer; A single center experience.
Sayan M; Bas A; Gokce A; Dikmen AU; Celik A; Kurul IC; Tastepe AI
Niger J Clin Pract; 2020 Jun; 23(6):829-834. PubMed ID: 32525119
[TBL] [Abstract][Full Text] [Related]
10. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
[TBL] [Abstract][Full Text] [Related]
11. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
12. [Long-term survival after lung-sparing central bronchoplastic procedures [CBPs] for malignant tumors].
Kecskés LI; Bátor G; Füredi A; Gehér P; Kiss B; Stankovics P
Magy Seb; 2013 Dec; 66(6):338-47. PubMed ID: 24333979
[TBL] [Abstract][Full Text] [Related]
13. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
[TBL] [Abstract][Full Text] [Related]
14. Is pneumonectomy after induction chemotherapy for non-small cell lung cancer a reasonable procedure? A multicenter retrospective study of 228 cases.
Thibout Y; Guibert B; Bossard N; Tronc F; Tiffet O; de la Roche E; Mulsant P; Gamondes JP; Baulieux J; Remontet L; Geriniere L; Souquet PJ
J Thorac Oncol; 2009 Dec; 4(12):1496-503. PubMed ID: 19745768
[TBL] [Abstract][Full Text] [Related]
15. Wedge bronchoplastic lobectomy for non-small cell lung cancer as an alternative to sleeve lobectomy.
Park SY; Lee HS; Jang HJ; Joo J; Kim MS; Lee JM; Zo JI
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):825-831.e3. PubMed ID: 22104687
[TBL] [Abstract][Full Text] [Related]
16. Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy.
Storelli E; Tutic M; Kestenholz P; Schneiter D; Opitz I; Hillinger S; Weder W
Eur J Cardiothorac Surg; 2012 Jul; 42(1):77-81. PubMed ID: 22290903
[TBL] [Abstract][Full Text] [Related]
17. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
18. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
19. Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.
Kappers I; van Sandick JW; Burgers SA; Belderbos JS; van Zandwijk N; Klomp HM
Lung Cancer; 2010 May; 68(2):222-7. PubMed ID: 19664843
[TBL] [Abstract][Full Text] [Related]
20. Sleeve lobectomy for bronchogenic cancers: factors affecting survival.
Fadel E; Yildizeli B; Chapelier AR; Dicenta I; Mussot S; Dartevelle PG
Ann Thorac Surg; 2002 Sep; 74(3):851-8; discussion 858-9. PubMed ID: 12238850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
